Bristol Myers receives positive opinion from CHMP

Bristol Myers Squibb receives a positive opinion from the CHMP for the CAR T cell therapy Abecma in previous treatment lines for relapsed and refractory triple class multiple myeloma.)This...

Related Keywords

Anne Kerber ,European Commission ,Bristol Myers Squibb ,European Union ,Head Of Late Stage Clinical Development ,Senior Vice President ,Late Stage Clinical Development ,Cellular Therapy ,Bristol Myers ,Markets ,